LAI, ELEONORA
 Distribuzione geografica
Continente #
EU - Europa 1.533
NA - Nord America 804
AS - Asia 631
AF - Africa 49
SA - Sud America 26
OC - Oceania 21
Totale 3.064
Nazione #
IT - Italia 1.163
US - Stati Uniti d'America 772
CN - Cina 310
DE - Germania 90
IN - India 75
JP - Giappone 67
GB - Regno Unito 62
HK - Hong Kong 34
IE - Irlanda 29
TW - Taiwan 28
FR - Francia 26
NL - Olanda 23
CA - Canada 22
BE - Belgio 19
KR - Corea 19
EG - Egitto 17
AU - Australia 16
TR - Turchia 15
PH - Filippine 13
SG - Singapore 13
PT - Portogallo 12
SE - Svezia 12
FI - Finlandia 11
TH - Thailandia 11
BR - Brasile 10
RO - Romania 10
AT - Austria 9
PL - Polonia 9
UA - Ucraina 9
VN - Vietnam 9
CH - Svizzera 8
IQ - Iraq 7
MX - Messico 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
CZ - Repubblica Ceca 6
ES - Italia 6
MA - Marocco 6
DZ - Algeria 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
PE - Perù 5
UG - Uganda 5
GR - Grecia 4
ID - Indonesia 4
LT - Lituania 4
PK - Pakistan 4
RU - Federazione Russa 4
BD - Bangladesh 3
AZ - Azerbaigian 2
CL - Cile 2
EE - Estonia 2
GT - Guatemala 2
IL - Israele 2
LU - Lussemburgo 2
MN - Mongolia 2
MT - Malta 2
NP - Nepal 2
SA - Arabia Saudita 2
TG - Togo 2
TZ - Tanzania 2
AL - Albania 1
AR - Argentina 1
BF - Burkina Faso 1
BG - Bulgaria 1
CD - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EC - Ecuador 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
LY - Libia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UY - Uruguay 1
Totale 3.064
Città #
Cagliari 911
Ashburn 69
Shanghai 62
Columbus 60
Fairfield 54
Santa Cruz 50
Houston 48
Beijing 46
Milan 34
Rome 30
Seattle 30
Dublin 28
Mumbai 19
Cambridge 18
Tokyo 18
Wilmington 17
Buffalo 16
Chicago 16
Woodbridge 16
Guangzhou 15
Los Angeles 15
Brussels 14
Ann Arbor 12
Cairo 12
Munich 12
Nanjing 12
Hangzhou 11
Boardman 10
San Diego 10
Helsinki 9
Naples 9
New York 9
Changchun 8
Dong Ket 8
London 8
Shenzhen 8
Central 7
Chengdu 7
Hyderabad 7
Istanbul 7
Osaka 7
Paris 7
Shenyang 7
Taipei 7
Bucharest 6
Guiyang 6
Hong Kong 6
Phoenix 6
Toronto 6
Atlanta 5
Baltimore 5
Bari 5
Bengaluru 5
Cedar Knolls 5
Changsha 5
Chongqing 5
Dallas 5
Florence 5
Frankfurt am Main 5
Fremont 5
Harwich 5
Heidelberg 5
Jinan 5
Lima 5
Singapore 5
Sydney 5
Washington 5
Zurich 5
Aurora 4
Bangkok 4
Chennai 4
Council Bluffs 4
Delhi 4
Greenbelt 4
Hat Yai 4
Lexington 4
Linz 4
Lucknow 4
Muizenberg 4
San Vendemiano 4
Seoul 4
Turin 4
Verona 4
Wuhan 4
Afragola 3
Amadora 3
Amsterdam 3
Andover 3
Ankara 3
Athens 3
Boulder 3
Braga 3
Bristol 3
Cagayan de Oro 3
Casablanca 3
Casoria 3
Central District 3
Chittagong 3
Cleveland 3
Genoa 3
Totale 2.017
Nome #
New therapeutic targets in pancreatic cancer, file e2f56ed8-ef81-3eaf-e053-3a05fe0a5d97 1.060
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression, file e2f56ed9-9d7e-3eaf-e053-3a05fe0a5d97 422
null, file e2f56ed5-2859-3eaf-e053-3a05fe0a5d97 376
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment, file 8ebc3cb7-4c88-4c30-befb-60bceaf06aed 291
Molecular-biology-driven treatment for metastatic colorectal cancer, file e2f56ed9-4e0d-3eaf-e053-3a05fe0a5d97 189
BRAF-mutant colorectal cancer, a different breed evolving, file e2f56ed8-5249-3eaf-e053-3a05fe0a5d97 164
From central to sentral (Serum angiogenesis central): Circulating predictive biomarkers to anti-VEGFR therapy, file e2f56ed9-ac71-3eaf-e053-3a05fe0a5d97 110
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study, file e2f56eda-924a-3eaf-e053-3a05fe0a5d97 80
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients, file e2f56eda-bd0b-3eaf-e053-3a05fe0a5d97 59
The role of fetal programming in human carcinogenesis - May the Barker hypothesis explain interindividual variability in susceptibility to cancer insurgence and progression?, file 7ff92b55-0103-42d3-8d15-6ec203def5ec 51
Immune Checkpoint Inhibitors in the Treatment of HCC, file e2f56eda-9def-3eaf-e053-3a05fe0a5d97 51
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples, file e2f56eda-4342-3eaf-e053-3a05fe0a5d97 50
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review, file 05e96b0e-8a56-466c-b839-5e82eea376b3 31
Investigating the Ovarian Microstructure in the Genera Helicolenus and Scorpaena (Teleostei, Sub‐Order Scorpaenoidei) with Implications for Ovarian Dynamics and Spawning, file e2f56eda-bbe6-3eaf-e053-3a05fe0a5d97 27
Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice, file e2f56eda-7cb4-3eaf-e053-3a05fe0a5d97 25
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma, file e2f56eda-5c59-3eaf-e053-3a05fe0a5d97 22
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world, file e2f56eda-d69d-3eaf-e053-3a05fe0a5d97 18
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study, file e2f56ed9-bcc1-3eaf-e053-3a05fe0a5d97 16
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment, file e2f56eda-5bf0-3eaf-e053-3a05fe0a5d97 15
null, file 22ea06ba-10a2-4145-bfd5-c3979ea35895 9
null, file e2f56eda-5bee-3eaf-e053-3a05fe0a5d97 7
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help, file 51224597-31e3-4974-ab30-3319d210f12c 6
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters, file 74a96b85-a1a9-4c1b-a81c-c688398d3af0 4
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma, file 35537551-176c-4b87-8cfc-285620818edd 2
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study, file e2f56ed9-a055-3eaf-e053-3a05fe0a5d97 2
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study, file e2f56eda-5b89-3eaf-e053-3a05fe0a5d97 2
Uncovering key targets of success for immunotherapy in pancreatic cancer, file e2f56eda-7532-3eaf-e053-3a05fe0a5d97 2
null, file e2f56eda-ac30-3eaf-e053-3a05fe0a5d97 2
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials, file e2f56eda-afbe-3eaf-e053-3a05fe0a5d97 2
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index, file e2f56eda-b9a7-3eaf-e053-3a05fe0a5d97 2
Soft tissue epithelioid vascular tumors: a practical clinico pathological diagnostic approach, file e2f56eda-d370-3eaf-e053-3a05fe0a5d97 2
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib, file 1fb7b739-d040-4ac3-bb4d-2be72fc1a76e 1
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients?, file e2f56ed8-ef7e-3eaf-e053-3a05fe0a5d97 1
BRCA-mutant pancreatic ductal adenocarcinoma, file e2f56eda-5c57-3eaf-e053-3a05fe0a5d97 1
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus, file e2f56eda-7bdd-3eaf-e053-3a05fe0a5d97 1
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?, file e2f56eda-7cb2-3eaf-e053-3a05fe0a5d97 1
Molecular-driven treatment for biliary tract cancer: the promising turning point, file e2f56eda-924c-3eaf-e053-3a05fe0a5d97 1
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation, file e2f56eda-ac2e-3eaf-e053-3a05fe0a5d97 1
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study, file e2f56eda-b117-3eaf-e053-3a05fe0a5d97 1
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients, file e2f56eda-c45a-3eaf-e053-3a05fe0a5d97 1
Totale 3.108
Categoria #
all - tutte 7.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 0 8
2019/2020166 8 4 2 4 47 44 17 5 5 4 1 25
2020/20211.057 27 42 36 302 223 69 72 53 38 44 75 76
2021/2022495 40 23 34 44 46 21 31 44 17 26 97 72
2022/2023560 38 30 68 58 29 27 43 48 59 70 48 42
2023/2024776 58 72 68 58 61 71 60 67 72 62 126 1
Totale 3.108